Discover Servier
Servier, founded in 1954, is the first French independent pharmaceutical group. We are present in 140 countries, with more than 20 000 employees, including close to 3000 in R&D.
 | Visit the clinical development center of Servier Canada |
Latest news
 |
ETNA-AF Registry Data Provide Real-world Evidence of the Efficacy and Safety Profile of LIXIANA® (edoxaban) in Elderly NonValvular Atrial Fibrillation Patients |
 |
 |
Servier Canada announces Positive Results of the ENTRUSTAF PCI Study of LIXIANA® (edoxaban) in Patients with Atrial Fibrillation |
|
 |
LIXIANA® (edoxaban) now reimbursed by the Régie de l’assurance maladie du Québec for patients with atrial fibrillation or venous thromboembolism |
|
